BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30849641)

  • 1. Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression.
    Jiang Y; Chen X; Wei Y; Feng Y; Zheng W; Zhang Z
    Biomed Pharmacother; 2019 May; 113():108712. PubMed ID: 30849641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
    Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
    Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.
    Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1077-85. PubMed ID: 22540333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism.
    Bai M; Yang L; Liao H; Liang X; Xie B; Xiong J; Tao X; Chen X; Cheng Y; Chen X; Feng Y; Zhang Z; Zheng W
    Oncogene; 2018 Oct; 37(42):5666-5681. PubMed ID: 29921847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism.
    Hu M; Sun D; Yu J; Fu Y; Qin Z; Huang B; Zhang Q; Chen X; Wei Y; Zhu H; Wang Y; Feng Y; Zheng W; Liao H; Li J; Wu S; Zhang Z
    Lab Invest; 2022 Dec; 102(12):1335-1345. PubMed ID: 36038734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.
    Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
    J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation.
    Xie BY; Lv QY; Ning CC; Yang BY; Shan WW; Cheng YL; Gu C; Luo XZ; Zhang ZB; Chen XJ; Xi XW; Feng YJ
    Biochem Biophys Res Commun; 2017 Jan; 482(4):857-862. PubMed ID: 27889612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.
    Cheng Y; Xie L; Xu Z; Hao M; Yang B; Shan W; Wang Y; Lv Q; Chen X
    Cancer Gene Ther; 2022 Oct; 29(10):1452-1462. PubMed ID: 35388173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.
    Wang Y; Wang Y; Zhang Z; Park JY; Guo D; Liao H; Yi X; Zheng Y; Zhang D; Chambers SK; Zheng W
    Oncotarget; 2016 Mar; 7(9):10363-72. PubMed ID: 26824415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ; Shi HR; Xie Y
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: a potential novel endometrial cancer therapy.
    Mu N; Wang Y; Xue F
    Int J Gynecol Cancer; 2012 Feb; 22(2):181. PubMed ID: 22274313
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
    Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
    Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
    Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
    Wang W; Li X; Wang F; Sun XY
    J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
    Wang J; Shi H; Xie Y; Peng Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
    Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
    FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.